CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 44 filers reported holding CIDARA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,009 | -39.9% | 55,200 | -27.9% | 0.00% | – |
| Q2 2023 | $86,558 | +7.2% | 76,600 | +20.4% | 0.00% | – |
| Q1 2023 | $80,772 | +313.9% | 63,600 | +146.5% | 0.00% | – |
| Q4 2022 | $19,513 | +8.4% | 25,800 | -8.5% | 0.00% | – |
| Q3 2022 | $18,000 | -5.3% | 28,200 | -27.1% | 0.00% | – |
| Q2 2022 | $19,000 | -85.3% | 38,694 | -74.9% | 0.00% | – |
| Q1 2022 | $129,000 | -81.4% | 154,394 | -71.7% | 0.00% | -100.0% |
| Q4 2021 | $694,000 | -33.9% | 546,294 | +16.6% | 0.00% | -33.3% |
| Q3 2021 | $1,050,000 | +1180.5% | 468,594 | +1054.3% | 0.00% | – |
| Q2 2021 | $82,000 | -65.3% | 40,594 | -54.3% | 0.00% | -100.0% |
| Q1 2021 | $236,000 | +242.0% | 88,794 | +156.2% | 0.00% | – |
| Q4 2020 | $69,000 | -52.7% | 34,654 | -32.6% | 0.00% | – |
| Q3 2020 | $146,000 | -54.8% | 51,394 | -41.4% | 0.00% | -100.0% |
| Q2 2020 | $323,000 | +254.9% | 87,654 | +137.8% | 0.00% | – |
| Q1 2020 | $91,000 | +68.5% | 36,854 | +163.2% | 0.00% | – |
| Q4 2019 | $54,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,627,670 | $1,533,591 | 1.88% |
| 5AM Venture Management, LLC | 1,134,511 | $1,068,936 | 0.31% |
| Nantahala Capital Management | 2,538,406 | $2,391,686 | 0.20% |
| BVF INC/IL | 6,861,127 | $6,464,554 | 0.17% |
| Monashee Investment Management LLC | 369,099 | $347,765 | 0.14% |
| West Family Investments, Inc. | 368,910 | $347,587 | 0.12% |
| JEPPSON WEALTH MANAGEMENT, LLC | 137,560 | $129,609 | 0.06% |
| XTX Topco Ltd | 202,758 | $191,039 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 136,974 | $129 | 0.01% |
| Callan Capital, LLC | 103,462 | $97,482 | 0.01% |